Wealth Science Advisors’s Cintas CTAS Stock Holding History

Wealth Science Advisors’s Portfolio CTAS Stock Details CTAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-440	Closed	-$82.8K	–	123
2026 Q1	$82.8K	Buy	+440	New	+$84.4K	0.05%	90

Other funds holding CTAS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Wealth Science Advisors's CTAS Position: Q2 2026 in Review

Wealth Science Advisors sold out of Cintas (CTAS) in Q2 2026, closing a stake of 440 shares — an estimated $82.8K sold.

Wealth Science Advisors first reported a position in CTAS in Q1 2026 and held it in 1 quarter. The position peaked at $82.8K in Q1 2026. 1,420 funds tracked by Wall St. Rank hold CTAS as of Q2 2026.

Wealth Science Advisors reported no remaining Cintas position as of Q2 2026 after selling out during the quarter.
Wealth Science Advisors sold 440 Cintas shares in Q2 2026, an estimated $82.8K.
Wealth Science Advisors first reported a position in Cintas in Q1 2026 and held it in 1 quarter.
Wealth Science Advisors's Cintas position peaked at $82.8K in Q1 2026.
1,420 funds tracked by Wall St. Rank held Cintas as of Q2 2026.

Based on Wealth Science Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.